Insider Transactions in Q3 2024 at Liquidia Corp (LQDA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2024
|
Paul B Manning Director |
BUY
Open market or private purchase
|
Indirect |
337,078
+29.23%
|
$2,696,624
$8.9 P/Share
|
|
Sep 12
2024
|
Caligan Partners LP Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,123,595
+12.16%
|
$8,988,760
$8.9 P/Share
|
|
Sep 03
2024
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
710
-0.15%
|
$6,390
$9.5 P/Share
|
|
Sep 03
2024
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
455
-0.39%
|
$4,095
$9.5 P/Share
|
|
Sep 03
2024
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
1,079
-0.34%
|
$9,711
$9.5 P/Share
|
|
Sep 03
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
546
-0.35%
|
$4,914
$9.5 P/Share
|
|
Aug 30
2024
|
Caligan Partners LP Director |
BUY
Open market or private purchase
|
Indirect |
150,000
+2.1%
|
$1,350,000
$9.51 P/Share
|
|
Aug 30
2024
|
Caligan Partners LP Director |
SELL
Open market or private sale
|
Indirect |
150,000
-2.14%
|
$1,350,000
$9.51 P/Share
|
|
Aug 30
2024
|
Caligan Partners LP Director |
SELL
Other acquisition or disposition
|
Indirect |
3,440,948
-32.97%
|
-
|
|
Aug 30
2024
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.48%
|
-
|
|
Aug 30
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+1.33%
|
-
|
|
Aug 30
2024
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.74%
|
-
|
|
Aug 30
2024
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+1.2%
|
-
|
|
Jul 26
2024
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,833
-1.59%
|
$20,163
$11.44 P/Share
|
|
Jul 19
2024
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,873
-0.89%
|
$20,603
$11.13 P/Share
|
|
Jul 12
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,528
-1.0%
|
$18,336
$12.53 P/Share
|
|
Jul 12
2024
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,053
-0.97%
|
$96,636
$12.53 P/Share
|
|
Jul 12
2024
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,470
-0.69%
|
$17,640
$12.53 P/Share
|
|
Jul 12
2024
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
1,985
-0.41%
|
$23,820
$12.53 P/Share
|
|
Jul 12
2024
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,146
-0.98%
|
$13,752
$12.53 P/Share
|
|
Jul 12
2024
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
3,906
-1.23%
|
$46,872
$12.53 P/Share
|
|
Jul 11
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,907
+3.25%
|
-
|